Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Abbott (ABT) has acquired Walk Vascular, a commercial-stage medical device company. Walk Vascular's peripheral thrombectomy systems will be incorporated into the company's endovascular product portfolio. Financial terms of the deal were not disclosed.


RTTNews | Sep 2, 2021 09:58AM EDT

09:58 Thursday, September 2, 2021 (RTTNews.com) - Abbott (ABT) has acquired Walk Vascular, a commercial-stage medical device company. Walk Vascular's peripheral thrombectomy systems will be incorporated into the company's endovascular product portfolio. Financial terms of the deal were not disclosed.

Walk Vascular's JETi Peripheral Thrombectomy System and next-generation JETi AIO Peripheral Thrombectomy System are aspiration systems for the removal of intravascular clots. The products have received 510(k) clearance from the FDA for the aspiration and breaking up of soft emboli and thrombus from the peripheral vasculature, as well as CE Mark in Europe and approvals in other countries.

Read the original article on RTTNews ( https://www.rttnews.com/3222959/abbott-announces-acquisition-of-walk-vascular-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC